Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/26/2013 | US8404944 Soybean variety A1023795 |
03/26/2013 | US8404943 Soybean variety A1023694 |
03/26/2013 | US8404942 Soybean variety A1023673 |
03/26/2013 | US8404941 Soybean variety A1023667 |
03/26/2013 | US8404940 Soybean variety A1023596 |
03/26/2013 | US8404939 Soybean variety A1023485 |
03/26/2013 | US8404938 Soybean variety A1022842 |
03/26/2013 | US8404936 Lettuce cultivar Refugio |
03/26/2013 | US8404935 Lettuce cultivar tiburon |
03/26/2013 | US8404934 Genes encoding nematode toxins |
03/26/2013 | US8404933 Herbicide resistance gene |
03/26/2013 | US8404932 Pea line EX 08570935 |
03/26/2013 | US8404931 Use of multiple transformation enhancer sequences to improve plant transformation efficiency |
03/26/2013 | US8404930 Methods for improving monocot transformation |
03/26/2013 | US8404929 Compositions and methods for modulating expression of gene products |
03/26/2013 | US8404928 Expression vector comprising nucleotide sequences which express cleavable short interfering nucleic acid for use as tool in controlling gene expression in plants |
03/26/2013 | US8404927 Double-stranded RNA stabilized in planta |
03/26/2013 | US8404926 Use of a seed specific promoter to drive ODP1 expression in cruciferous oilseed plants to increase oil content while maintaining normal germination |
03/26/2013 | US8404832 Short interfering ribonucleic acid (siRNA) for oral administration |
03/26/2013 | US8404831 Short interfering ribonucleic acid (siRNA) for oral administration |
03/26/2013 | US8404827 Environmental stress-inducible 996 promoter isolated from rice and uses thereof |
03/26/2013 | US8404826 Mycobacterial antigens expressed under low oxygen tension |
03/26/2013 | US8404823 Cytokine production regulator gene and use thereof |
03/26/2013 | US8404814 Anti-EDB antibody-targeted IL-10 cytokine for therapy of rheumatoid arthritis |
03/26/2013 | US8404807 Mammalian tumor susceptibility genes and their uses |
03/26/2013 | US8404805 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
03/26/2013 | US8404659 Pharmaceutical compositions for treatment of MicroRNA related diseases |
03/26/2013 | US8404658 RNA interference for the treatment of heart failure |
03/26/2013 | US8404657 Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (Tlx) |
03/26/2013 | US8404656 Methods of treatment and prevention of diet-induced obesity and sequelae thereof |
03/26/2013 | US8404486 Recombination sequences |
03/26/2013 | US8404472 System for producing aromatic molecules by bioconversion |
03/26/2013 | US8404471 Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities |
03/26/2013 | US8404469 Embedded enzymes in polymers to regulate their degradation rate |
03/26/2013 | US8404468 Efficient astaxanthin production strains derived from Haematococcus pluvialis |
03/26/2013 | US8404466 Metabolically enhanced photoautotrophic ethanol producing host cells, method for producing the host cells, constructs for the transformation of the host cells, and method of producing ethanol using the host cells |
03/26/2013 | US8404465 Biological synthesis of 6-aminocaproic acid from carbohydrate feedstocks |
03/26/2013 | US8404439 Methods and compositions for isolating small RNA molecules |
03/26/2013 | US8404242 Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities |
03/26/2013 | US8404233 Neutralizing monoclonal antibody against human DLL4 |
03/26/2013 | CA2791109A1 Generation of binding molecules |
03/26/2013 | CA2580796C Modified fc molecules having peptides inserted in internal loop regions |
03/26/2013 | CA2551602C Methods for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity |
03/26/2013 | CA2549097C Method of producing arachidonic acid-containing plants |
03/26/2013 | CA2534296C Methods and compositions for targeted cleavage and recombination |
03/26/2013 | CA2513899C Methods of amplifying and sequencing nucleic acids |
03/26/2013 | CA2470308C Phospholipid:diacylglycerol acyltransferases |
03/26/2013 | CA2424867C A kit for detecting non-pathogenic or pathogenic influenza a subtype h5 virus |
03/26/2013 | CA2424207C Stem cell differentiation-inducing promoter |
03/26/2013 | CA2379166C Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs |
03/26/2013 | CA2356621C Assay for identifying compounds which affect stability of mrna |
03/26/2013 | CA2312000C Mammalian cytokine-like polypeptide-10 |
03/26/2013 | CA2262459C Gene involved in cadasil, method of diagnosis and therapeutic application |
03/21/2013 | WO2013040577A1 Aptamers resistant to nucleocapsid degradation |
03/21/2013 | WO2013040572A2 Compositions and methods for the production and use of human cholinesterases |
03/21/2013 | WO2013040552A2 Methods of promoting immune tolerance |
03/21/2013 | WO2013040548A2 Fluoride-responsive riboswitchs, fluoride transporters, and methods of use |
03/21/2013 | WO2013040491A2 Probe: antiprobe compositions for high specificity dna or rna detection |
03/21/2013 | WO2013040439A2 CBP and p300-MEDIATED TRANSCRIPTION MODULATORS AND RELATED METHODS |
03/21/2013 | WO2013040436A2 Esx-mediated transcription modulators and related methods |
03/21/2013 | WO2013040429A1 Multimeric oligonucleotide compounds |
03/21/2013 | WO2013040393A2 Genes contributing to survival of cancer cells |
03/21/2013 | WO2013040383A1 Microorganisms and methods for producing alkenes |
03/21/2013 | WO2013040353A1 Plants having stress related traits and methods for making the same |
03/21/2013 | WO2013040341A2 Wnt7a compositions and methods of using the same |
03/21/2013 | WO2013040309A2 Wnt compositions and therapeutic uses of such compositions |
03/21/2013 | WO2013040259A1 Soybean bbi3 promoter and its use in embryo-specific expression of transgenic genes in plants |
03/21/2013 | WO2013040216A2 Digital bridge pcr |
03/21/2013 | WO2013040213A1 Soybean atps promoter and its use in constitutive expression of transgenic genes in plants |
03/21/2013 | WO2013040117A1 Methods and compositions for weed control |
03/21/2013 | WO2013040116A1 Methods and compositions for weed control |
03/21/2013 | WO2013040071A2 Sperm protein as a detection biomarker of early stage ovarian cancer |
03/21/2013 | WO2013040062A2 Characterizing multiple sclerosis |
03/21/2013 | WO2013040060A2 Nucleic acids for multiplex detection of hepatitis c virus |
03/21/2013 | WO2013040033A1 Methods and compositions for weed control |
03/21/2013 | WO2013040021A1 Methods and compositions for weed control |
03/21/2013 | WO2013040005A1 Methods and compositions for weed control |
03/21/2013 | WO2013039990A1 Methods and compositions for weed control |
03/21/2013 | WO2013039563A1 Production of odd chain fatty acid derivatives in recombinant microbial cells |
03/21/2013 | WO2013039378A1 A method for regulating cytosolic isoprenoid biosynthesis in hevea brasiliensis |
03/21/2013 | WO2013039295A1 Novel alpha 1-antitrypsin variant, preparation method thereof, and use thereof |
03/21/2013 | WO2013039228A1 Method for detecting target nucleic acid |
03/21/2013 | WO2013039166A1 Method for measuring anti-wt1 antibody |
03/21/2013 | WO2013039087A1 Method for screening for substance |
03/21/2013 | WO2013039069A1 Novel recombinant bcg vaccine |
03/21/2013 | WO2013038907A1 Method for inhibiting cell growth, nucleic acid molecule having rna interference effect on nek10 variant gene, and anticancer agent |
03/21/2013 | WO2013038740A1 Method for screening for substance or factor capable of promoting muscle hypertrophy |
03/21/2013 | WO2013038737A1 Method for detecting bladder cancer cells, primer used in method for detecting bladder cancer cells, and bladder cancer marker |
03/21/2013 | WO2013038696A1 Molecular marker for early indentification of pleural mesothelioma patients, and expression analysis method for same |
03/21/2013 | WO2013038666A1 Light-induced seizure model in rat brains |
03/21/2013 | WO2013038604A1 Nucleic acid purification method, nucleic acid extraction method, and nucleic acid purification kit |
03/21/2013 | WO2013038534A1 Method for detecting target nucleic acid |
03/21/2013 | WO2013038376A1 Increase in meiotic recombination in plants by inhibiting the fancm protein |
03/21/2013 | WO2013038303A1 Plants having enhanced yield-related traits and methods for making the same |
03/21/2013 | WO2013038294A1 Regulatory nucleic acid molecules for reliable gene expression in plants |
03/21/2013 | WO2013038272A2 Streptavidin mutein exhibiting reversible binding for biotin and streptavidin binding peptide tagged proteins |
03/21/2013 | WO2013038203A1 Thermostable assay reagents |
03/21/2013 | WO2013038202A2 Over-expression of gcn2-type protein kinase in plants |
03/21/2013 | WO2013038066A1 Modified oncolytic vaccinia virus |
03/21/2013 | WO2013038062A1 Enzyme variants with improved properties |